(CNN) – United States may hold a dose increase of vacancies against the covid-19 estimated at $ 300 million by the end of July, according to the Duke University.
Investigators are using data on early-stage compromises from the United States Government with the pharmaceutical giants to read the estimate.
The country has vacancies with Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Novavax.
The vacancies of AstraZeneca and Novavax have not yet received EE.UU emergency authorization, according to the Food and Drug Administration (FDA).
The authors of the information also revise the chronograms of production of vacancies and use data from the census of the United States to estimate the demand.
His estimate is that the nation retains sufficient doses for the mayor of the minorities of the country.
The excess of vacancies in EE.UU.
The investigators also assume that 75% of the United States population will receive a dose vaccine and 25% will receive a Johnson & Johnson vaccine from a single injection.
However, the recent pause in the use of the Johnson & Johnson vacancy in the United States makes it possible for its projections not to be accurate.
Independently, United States and other richer countries will hope to have an excess of vacancies in the future, write the authors.
Currently, 10 countries representing less than the world population have used three quarters of the dose of the vaccine against covid-19, but many more poor countries have no tenant.
“The richest nations in the world have secured the sum of the summit in the short court. In the current rhythm that administers the vacancies, 92 of the world’s poorest countries will not vacate 60% of their population by 2023 or later, ”writes Dr. Krishna Udayakumar, Director of the Duke Global Health Innovation Center and Dr. Mark McClellan, Director of the Duke-Margolis Sanitary Policy Center.
“Now is the time to move forward with a plan to distribute additional doses in excess of what is currently available.”
Authors say that United States should invest more in overcoming the consequences of the Covax vaccine program and make sure that the excess doses are available to other nations.
We also write that United States should support other nations in order to produce vacancies on their account.